GRACE :: Head/Neck Cancer

cetuximab

Denise Brock

ASCO 2017 – Head and Neck Cancer – Alternatives to Every Three Week Cisplatin Currently Used in Practice, Weekly Cisplatin & Cetuximab

Share

Dr. Jared Weiss, University of North Carolina School of Medicine

Dr. Siddharth Sheth, University of North Carolina

Joshua Bauml, MD, University of Pennsylvania


Drs. Jared Weiss, Associate Professor, of Medicine, University of North Carolina School of Medicine, Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, and Siddharth Sheth, Hematology Oncology Fellow at the University of North Carolina, gathered post meeting to discuss new information from ASCO 2017 regarding head and neck cancers.   In this roundtable video, the doctors discuss Alternatives to Every Three Week Cisplatin Currently Used in Practice, Weekly Cisplatin & Cetuximab.


 

 

 


 Please feel free to offer comments and raise questions in our Discussion Forums.


GRACE would like to thank the following sponsors for their support of this program

  

     

 

 

 

 

 

 


Late Stage Oropharynx Cancer, Chemotherapy – Options and Practice by Dr. Weiss

Share

Graphic of EGFR signaling with CetuximabDr. Jared Weiss, University of North Carolina, discusses chemotherapy options and practice in late stage oropharynx cancer.

 

Late Stage Oropharynx Cancer, Chemotherapy – Options and Practice Audio Podcast

 

What you will hear in part 4

  • Adding chemotherapy to oropharynx cancer treatment
  • What is chemo and how does it work?
  • Side effects and side effect management

 

Glossary of terms you will hear in part 4

For other cancer-related definitions, visit the National Cancer Institute’s online glossary at cancer.gov/dictionary.

  • Cetuximab – A drug used to treat certain types of head and neck cancer, and a certain type of colorectal cancer that has spread to other parts of the body. Cetuximab binds to a protein called epidermal growth factor receptor (EGFR), which is on the surface of some types of cancer cells. This may stop cancer cells from growing. Cetuximab is a type of monoclonal antibody. Also called Erbitux.
  • Chemotherapy – Treatment with drugs that kill cancer cells.
  • Cisplatin – A drug used to treat malignant head and neck cancer. Cisplatin contains the metal platinum. It kills cancer cells by damaging their DNA and stopping them from dividing.
  • Definitive treatment – The treatment plan for a disease or disorder that has been chosen as the best one for a patient after all other choices have been considered.
  • Epidermal Growth Factor Receptor (EGFR) – The protein found on the surface of some cells and to which epidermal growth factor binds, causing the cells to divide. It is found at abnormally high levels on the surface of many types of cancer cells, so these cells may divide excessively in the presence of epidermal growth factor. Also called ErbB1 and HER1.

 


Ask Us, Q&A
Head/Neck Cancer Expert Content

Archives

Share

GRACE Cancer Video Library - Lung Cancer Videos

 

2015_Immunotherapy_Forum_Videos

 

2015 Acquired Resistance in Lung Cancer Patient Forum Videos

Share

Join the GRACE Faculty

Lung/Thoracic Cancer Blog
Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Share

Subscribe to the GRACEcast Podcast on iTunes

Share

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
   (Free Newsletter)

Other Resources

Share

ClinicalTrials.gov


Biomedical Learning Institute

peerview_institute_logo_243